Abstract Disease Overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Disease overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Disease overview: Follicular lymphoma (FL) is generally an indolent B‐cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …

Background Rituximab plus chemotherapy has been shown to be effective in patients with
advanced-stage, previously untreated follicular lymphoma; nevertheless, most patients will …

Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal
centre (GC) B cell differentiation. FL represents~ 5% of all haematological neoplasms and …

Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma in the
Western hemisphere. After decades of stagnation, the natural history of FL appears to have …

Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co …